Allgens Medical Technology Co Ltd (688613)

Currency in CNY
19.76
+0.51(+2.65%)
Closed·

688613 Financial Summary

Key Ratios

P/E Ratio-132.76
Price/Book1.8
Debt / Equity3.54%
Return on Equity-1.6%
Dividend Yield0.00%
EBITDA-10.34M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
0.01 / --
Revenue / Forecast
42.46M / --
EPS Revisions
Last 90 days

FAQ

What were Allgens Medical Technology Co's earnings for the latest quarter?

The Allgens Medical Technology Co EPS (TTM) is -0.14. Allgens Medical Technology Co reported sales of 42.46, net income of 1.04, and EPS of 0.01 for the latest quarter.

What was Allgens Medical Technology Co's net income for the latest quarter?

Allgens Medical Technology Co's net income for the latest quarter was 1.04.

How did Allgens Medical Technology Co's performance compare year-over-year in the latest quarter?

The company's revenue moved from 57.72 in the previous quarter to 42.46 in the latest quarter, and net income moved from -17.55 to 1.04 compared to the previous quarter.

What is Allgens Medical Technology Co's net profit margin on a TTM basis?

Allgens Medical Technology Co's trailing twelve months (TTM) net profit margin is -6.15%.

How does Allgens Medical Technology Co's debt to equity ratio compare to industry standards?

Allgens Medical Technology Co's total debt-to-equity ratio is 3.54%.

What is Allgens Medical Technology Co's return on investment on a TTM basis?

Allgens Medical Technology Co's trailing twelve months (TTM) return on investment (ROI) is -1.60%.

Did Allgens Medical Technology Co gain or lose cash last quarter?

In the latest quarter, Allgens Medical Technology Co's net change in cash was -20.28 million.

What were Allgens Medical Technology Co's total assets and liabilities in the latest quarter?

As of the latest quarter, Allgens Medical Technology Co reported total assets of 1,557.56 million and total liabilities of 66.36 million.

How has Allgens Medical Technology Co's total revenue grown this year?

Allgens Medical Technology Co's total revenue was 57.72 in the previous quarter and 42.46 in the latest quarter.

What is Allgens Medical Technology Co's gross margin on a TTM basis?

Allgens Medical Technology Co's trailing twelve months (TTM) gross margin is 66.79%.

What was Allgens Medical Technology Co's revenue per share for the latest quarter?

Allgens Medical Technology Co's revenue per share for the latest quarter was 6.46.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.